Fluidigm raises another $7.5M for stem-cell analysis chips

Fluidigm, which makes chips that for genetics lab, has raised $7.5 million in new equity, according to VentureWire. That’s part of a new $18.5 million round that the South San Francisco, Calif. company is raising. The funding comes from existing backers Alloy Ventures, EDB Investments, EuclidSR partners, Fidelity Contrafund, Interwest Partners, Lehman Brothers Venture Capital Group, Smallcap World Fund, and Versant Ventures, as well as an undisclosed new investor.